Gliknik Inc. Adds Incyte Corporation (INCY) President & CEO Paul A. Friedman to its Board of Directors
2/25/2013 8:56:34 AM
More...
|
Gliknik Inc. Announces Interim Clinical Data From Use of Its Immunomodulator Drug Candidate in Multiple Myeloma Patients
12/20/2012 9:56:53 AM
More...
|
Gliknik Inc. Raises $4.9 Million in Series B Financing Led by Baxter Ventures
10/8/2012 10:41:44 AM
More...
|
Published Preclinical Data Demonstrate Ability of Gliknik Inc.'s Recombinant Stradomers™ to Mimic Anti-Autoimmune Effect of IVIG
9/12/2012 12:07:29 PM
More...
|
National Cancer Institute Awards Gliknik Inc. Up to $1.5 Million in SBIR Funding
10/3/2011 12:32:35 PM
More...
|
Gliknik Inc. Announces Completion of $3.5 Million Equity Financing
1/5/2011 8:54:22 AM
More...
|
2008 Mid-Atlantic Bio Exhibitor Profiles
10/21/2008 11:36:47 AM
More...
|
University of Maryland, Baltimore BioPark Signs Gliknik Inc. First Tenant in Its BioInnovation Center in Building Two
1/10/2008 7:56:24 AM
More...
|